Therefore, xCT is highly expressed by a variety of malignant tumors such as lymphoma, glioma, breast carcinoma, and prostate cancer (Gout et al., 2001; Narang et al., 2003; Chung et al., 2005; Doxsee et al., 2007). Here, SLC7A11 is linked to cancer.